<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<doc>
  <docno>
    <textblock>FR940110-2-00009</textblock>
  </docno>
  <parent>
    <textblock>FR940110-2-00008</textblock>
  </parent>
  <text>
    <textblock>Pursuant to its authority under the Foreign-Trade Zones Act of June 18, 1934, as amended (19 U.S.C. 81a-81u), the Foreign-Trade Zones Board (the Board) adopts the following Order: Grant of authority for subzone status, SmithKline Beecham Pharmaceuticals Co., (Pharmaceutical Products),</textblock>
    <textblock>Cidra, Puerto Rico.</textblock>
    <textblock>Whereas, by an Act of Congress approved June 18, 1934, an Act ``To provide for the establishment *␣*␣* of foreign-trade zones in ports of entry of the United States, to expedite and encourage foreign commerce, and for other purposes,'' as amended (19 U.S.C. 81a-81u) (the Act), the Foreign-Trade Zones Board (the Board) is authorized to grant to qualified corporations the privilege of establishing foreign-trade zones in or adjacent to U.S. Customs ports of entry;</textblock>
    <textblock>Whereas, the Board's regulations (15 CFR Part 400) provide for the establishment of special-purpose subzones when existing zone facilities cannot serve the specific use involved;</textblock>
    <textblock>Whereas, an application from the Puerto Rico Commercial and Farm Credit and Development Corporation, grantee of Foreign-Trade Zone 61 (San Juan, Puerto Rico), for authority to establish a special-purpose subzone at the pharmaceutical manufacturing plant of SmithKline Beecham Pharmaceuticals Company, located in Cidra, Puerto Rico, was filed by the Board on January 15, 1993, and notice inviting public comment was given in the</textblock>
    <textblock>Federal Register</textblock>
    <textblock>(FTZ Docket 1-93, 58 FR 7529, 2-8-93); and,</textblock>
    <textblock>Whereas, the Board has found that the requirements of the Act and Board's regulations are satisfied, and that approval of the application is in the public interest;</textblock>
    <textblock>Now, therefore, the Board hereby authorizes the establishment of a subzone (Subzone 61C) at the SmithKline Beecham Pharmaceuticals Company plant in Cidra, Puerto Rico, at the location described in the application, subject to the FTZ Act and the Board's regulations, including §400.28.</textblock>
    <textblock>Signed at Washington, DC, this 29th day of December 1993.</textblock>
  </text>
  <rindock>
    <textblock>[Order No. 679]</textblock>
  </rindock>
  <doctitle>
    <textblock>SmithKline Beecham Pharmaceuticals Co., Cidra, Puerto Rico; Application</textblock>
  </doctitle>
  <signer>
    <textblock>Barbara R. Stafford</textblock>
  </signer>
  <signjob>
    <textblock>Acting Assistant Secretary of Commerce for Import Administration, Chairman, Committee of Alternates, Foreign-Trade Zones Board.</textblock>
    <textblock>Attest:</textblock>
  </signjob>
  <signer>
    <textblock>John J. Da Ponte, Jr.,</textblock>
  </signer>
  <signjob>
    <textblock>Executive Secretary.</textblock>
  </signjob>
  <frfiling>
    <textblock>[FR Doc. 94-508 Filed 1-7-94; 8:45 am]</textblock>
  </frfiling>
  <billing>
    <textblock>BILLING CODE 3510-DS-P</textblock>
  </billing>
</doc>
